Skip to main content
Equibles

MetLife Investment Management, LLC

Position in CERS — Cerus Corp

CIK 1529735 Whippany, NJ
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$345,351
+$229,751 QoQ
Shares Held
118,271
+86.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $231,772,552 across 68 Medical Devices names. CERS ranks #44 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 398,341 $36,145,462
2 SYK
Stryker Corp
 78,948 $24,855,988
3 MDT
Medtronic plc
 293,703 $22,976,385
4 BRKR
Bruker Corp
 374,119 $22,514,481
5 GMED
Globus Medical Inc
 275,556 $21,771,679
6 BSX
Boston Scientific Corp
 339,986 $14,510,602
7 EW
Edwards Lifesciences Corp
 131,633 $11,907,521
8 DXCM
Dexcom Inc
 103,307 $6,957,726

All Filings in CERS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $345,351 118,271
2026-03-31 $115,600 63,517
2025-12-31 $188,733 91,618
2025-09-30 $132,256 83,180
2025-06-30 $156,178 110,765
2025-03-31 $153,279 110,273
2024-12-31 $80,311 52,150
2024-09-30 $178,758 102,735
2024-06-30 $180,813 102,735
2024-03-31 $171,829 90,915
2023-12-31 $197,097 91,249
2023-09-30 $147,823 91,249
2023-06-30 $224,472 91,249
2023-03-31 $271,009 91,249
2022-12-31 $302,866 82,977
2022-09-30 $332,712 92,420
2022-06-30 $399,664 75,551
2022-03-31 $510,504 92,988
2021-12-31 $407,333 59,814
2021-09-30 $314,152 51,585
2021-06-30 $382,518 64,724
2021-03-31 $388,991 64,724
2020-12-31 $473,777 68,465
2020-09-30 $442,312 70,657
2020-06-30 $466,336 70,657
2020-03-31 $328,555 70,657